PharmaBioAge Labs wants to raise $200 million in IPO to develop obesity and diabetes drugsBy Bruce Gil and Andy MillsPublished September 25, 2024Share to TwitterShare to FacebookShare to RedditShare to EmailShare to Link📬 Sign up for the Daily BriefOur free, fast and fun briefing on the global economy, delivered every weekday morning.Sign me up
